Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined CPT and SGB for PTSD
NCT06570213Phase 1Recruiting
- Sponsor
- Rush University Medical Center
- Start
- Apr 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in post-traumatic stress disorder (PTSD) (3 arms), sponsored by Rush University Medical Center. Primary endpoints: Clinician Administered PTSD Scale for DSM-5 at 6 months and PTSD Checklist for DSM-5 at 6 months. Started Apr 2026; status: recruiting.
02
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06570213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06570213.